Sentinel lymph node biopsy in melanoma: The gulf between presentation and reality

SKINmed

Volumn 8, Issue 4, 2010, Pages 222-224

  Meirion Thomas, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE FREE SURVIVAL; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; METHODOLOGY; PATHOLOGY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TIME;

DISEASE-FREE SURVIVAL; FALSE POSITIVE REACTIONS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 79952112735     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Note

References (18)

1. Voit C, van Akkooi AC, Schafer-Hesterberg G, et al. Rotterdam criteria for sentinel node (SN) tumour burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol. 2009;27:4994-5000.
2. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317.
3. Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol. 2008;5:18-23.
4. Thomas JM. Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenopathy Trial (MSLT-1) in patients with melanoma. J Plast Reconstr Aesthet Surg. 2009;62:442-446.
5. Morton DL, Hoon DSB, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg. 2003;238:538-549.
6. Langer I, Guller U, Viehl CT. Axillary lymph node dissection for sentinel lymph node metastases may be safely omitted in early-stage breast cancer patients. Ann Surg Oncol. 2009;16:3366-3374.
7. van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17:1578-1585.
8. Murughar P, Azawi K, Humzah D. The sleeper cells: delayed sentinel lymph node biopsy. J Plast Reconstr Aesthet Surg. 2007;60:1357-1360.
9. Cochran AJ, Thompson JF. Lymphatic mapping in sentinel node biopsy: the data unchanged by speculation. Arch Dermatol. 2008;144:687-689.
10. Morton DL, Elashoff R. Sentinel node biopsy: facts to clear the alleged clouds. Arch Dermatol. 2008;144:685-687.
11. Cochran AJ, Ohsie SJ, Binder SW. Pathology of the sentinel node. Curr Opin Oncol. 2008;20:190-195.
12. Balch CM, Morton DL, Gershenwald JE, et al. Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol. 2009;60:872-875.
13. Sondak VK. Nonsentinel node metatases in melanoma: do they reflect the biology of the tumour, the lymph node or the surgeon? Ann Surg Oncol. 2009;16:2965-2967.
14. Kretschmer L, Thomas KM, Peeters S, et al. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res. 2008;18:16-21.
15. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol. 2003;10:681-688.
16. Thompson JF, Scolyer RA, Kefford RF, et al. Melanoma management in 2007. Aust Fam Physician. 2007;36:487-488.
17. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-6206.
18. Strauss DC, Thomas JM. What does the medical profession mean by “standard of care”? J Clin Oncol. 2009;27:e192-e193.